![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/FERMENTA.png)
Share the post "FERMENTA BIOTECH ‘s Q3 2024-25 Latest News: Profit Grows by 279.28% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company experienced a substantial growth of 58.1 % in the past year, substantial increase in net sales/revenue by 64.66 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -11.77 %, Marginal decrease of -22.67% in other income during this quarter. 🔹 Profit over the Year and quarter: Significant improvement in profitability for FERMENTA BIOTECH LIMITED. Notable increase of 279.28 % in net profit Year to Year, FERMENTA BIOTECH LIMITED’s profitability increased by 240.68 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 272.73 % Year to Year. EPS increased by 222.59 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 98.967 Cr | Rs. 95.028 Cr | Rs. 156.47 Cr | + 64.66 % | + 58.1 % |
| Expenses | Rs. 73.85 Cr | Rs. 76.25 Cr | Rs. 103.2 Cr | + 35.34 % | + 39.74 % |
| Operating Profit | Rs. 25.12 Cr | Rs. 18.78 Cr | Rs. 53.27 Cr | + 183.65 % | + 112.06 % |
| OPM % | 25.38 % | 19.76 % | 34.04 % | + 14.28 % | + 8.66 % |
| Other Income | Rs. 2.524 Cr | Rs. 2.88 Cr | Rs. 2.227 Cr | -22.67 % | -11.77 % |
| Interest | Rs. 5.19 Cr | Rs. 3.69 Cr | Rs. 4.08 Cr | + 10.57 % | -21.39 % |
| Depreciation | Rs. 6.38 Cr | Rs. 6.15 Cr | Rs. 6.08 Cr | -1.14 % | -4.7 % |
| Profit before tax | Rs. 16.07 Cr | Rs. 11.82 Cr | Rs. 45.34 Cr | + 283.59 % | + 182.14 % |
| Tax % | 37.85 % | 5.92 % | 16.43 % | + 10.51 % | -21.42 % |
| Net Profit | Rs. 9.99 Cr | Rs. 11.12 Cr | Rs. 37.89 Cr | + 240.74 % | + 279.28 % |
| EPS in Rs | Rs. 3.41 | Rs. 3.94 | Rs. 12.71 | + 222.59 % | + 272.73 % |
Today, we’re looking at FERMENTA BIOTECH LIMITED’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 58.1 %. However, it did see a marginal increase of 64.66 % from the previous quarter. Expenses ticked up slightly by 35.34 % quarter-on-quarter, aligning with the annual rise of 39.74 %. Operating profit, while up 112.06 % compared to last year, faced a quarter-on-quarter increase of 183.65 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 8.66 %, but an expansion of 14.28 % sequentially. Other income fell by -22.67 % compared to the last quarter, despite an annual decline of -11.77 %. Interest expenses surged remarkably by 10.57 % from the previous quarter, yet the year-over-year decrease remains at a moderate -21.39 %. Depreciation costs fell by -1.14 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -4.7 %. Profit before tax grew annually by 182.14 % but saw an increase from the preceding quarter by 283.59 %.
Tax expenses as a percentage of profits decreased slightly by -21.42 % compared to last year, with a more notable quarter-on-quarter increase of 10.51 %. Net profit rose by 279.28 % year-on-year but experienced a 240.74 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 272.73 % but a quarterly rise of 222.59 %. In summary, FERMENTA BIOTECH LIMITED’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 98.967 Cr | Rs. 95.028 Cr | Rs. 156.47 Cr | + 64.66 % | + 58.1 % |
| Expenses | Rs. 73.85 Cr | Rs. 76.25 Cr | Rs. 103.2 Cr | + 35.34 % | + 39.74 % |
| Operating Profit | Rs. 25.12 Cr | Rs. 18.78 Cr | Rs. 53.27 Cr | + 183.65 % | + 112.06 % |
| Net Profit | Rs. 9.99 Cr | Rs. 11.12 Cr | Rs. 37.89 Cr | + 240.74 % | + 279.28 % |
| EPS in Rs | Rs. 3.41 | Rs. 3.94 | Rs. 12.71 | + 222.59 % | + 272.73 % |
In reviewing FERMENTA BIOTECH LIMITED’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 58.1 % year-on-year growth, however, there was a minor increase of 64.66 % from the previous quarter. Expenses rose by 39.74 % compared to the previous year, with a 35.34 % increase quarter-on-quarter. Operating Profit surged by 112.06 % annually, and saw a 183.65 % increase from the last quarter.
Net Profit showed yearly increase of 279.28 %, and experienced a 240.74 % increase from the previous quarter. Earnings Per Share (EPS) rose by 272.73 % annually, however rose by 222.59 % compared to the last quarter. In essence, while FERMENTA BIOTECH LIMITED exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/INDRAMEDCO.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/QUADRANT.png)